Quentin Van Thillo; Cedric Hermans/LinkedIn
Nov 7, 2025, 03:20
Insights on Rebalancing Agents in Hemophilia from Cédric Hermans and Quentin Van Thillo
World Federation of Hemophilia (WFH) shared on LinkedIn:
”Rebalancing agents are reshaping hemophilia treatment—but key questions remain.
What do we know, where are the uncertainties, and how do we move forward responsibly?”
Read the full article in Haematologica.
Article: Rebalancing agents in hemophilia: knowns, unknowns, and uncertainties
Authors: Quentin Van Thillo, Cédric Hermans
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD